(RTTNews) – European actions rose sharply on Monday, as hopes for a remedy for coronaviruses and the symptoms of a meltdown in tensions between the United States and China offset fears of a resurgence of virus cases across the continent.
Investor sentiment was reinforced after U.S. regulators legalized the use of blood plasma from recovered patients as a remedy option for Covid-19.
The U.S. FDA’s emergency approval came on the eve of the Republican National Convention, where Donald Trump will be nominated to lead his party for 4 years.
Meanwhile, a Bloomberg report that mentions others familiar with the issue says Trump’s team is privately looking to reassure U.S. corporations that they can still do business with the WeChat messaging app in China.
AstraZeneca shares rose 3.3%. The Financial Times reported that Trump’s management is contemplating accelerating the progression of a Covid-19 experimental vaccine through AstraZeneca Plc and Oxford University to bring economics closer to normal.
Spanish pharmaceutical and chemical multinational Grifols adds 3.3%.
BT Group shares rose 5.6%. Sky News reported that the telecommunications giant had asked Goldman Sachs to update its defense strategy against suitors.
Bunzl rose by almost 3% after the distribution and outsourcing company resumed dividends and increased its profits by 16.6% in the first half.
Insurer Axa SA grew by 2%. The company announced an agreement with Bharti Enterprises of India to consolidate its non-life insurance in India, Bharti AXA General Insurance Company Limited or Bharti AXA GI, at ICICI Lombard General Insurance Co. Ltd.